Procurement Of Inj. Eculizumab 300mg

Work Description - Procurement Of Inj. Eculizumab 300mg

All India Institute of Medical Science-New Delhi, a Central Government Ministry/Department, invites open tenders for the Procurement of Inj. Eculizumab 300mg, as detailed in Tender Reference Number 27/H/Inj.Eculizumab300mg/25-26. This is a Goods tender with Tender ID 2025_AIMSD_879205_1, categorized under Drugs and Pharmaceutical Products, and is an Open Tender. Bidders are required to submit a fixed EMD of ₹50,000 payable to AIIMS Main Grant at New Delhi. The tender documents, including the NIT and BOQ, are available for download from September 29, 2025, 04:00 PM until October 20, 2025, 04:00 PM. Bid submission commences on October 6, 2025, 04:00 PM, and closes on October 20, 2025, 04:00 PM. The bid opening date is scheduled for October 21, 2025, 04:00 PM at Main Hospital Store, AIIMS New Delhi. The contract type is Tender, with a work period of 45 days and bid validity of 270 days. The tender involves a two-cover system: Cover 1 requires a scanned copy of the EMD and other technical documents as per Section VII, while Cover 2 contains the Price Bid as per the BOQ format. Acceptable payment instruments include Demand Draft, FDR, and Bank Guarantee. The Tender Inviting Authority is Sr. Store Officer on behalf of Director AIIMS, located at Main Hospital Store, AIIMS New Delhi, Pincode 110030.